24 Jan 2018 | 7:59 AM
 

Bafna Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532989 | NSE Symbol: BAFNAPHARM
25.00
-0.45
(-1.76 %)
23 Jan 2018 | 03:48 PM
Change company
  • Open (Rs)
    25.50
  • Prev. close (Rs.)
    25.45
  • High (Rs.)
    25.85
  • Low (Rs.)
    24.70
  • 52W H (Rs.)
    33.30
  • 52W L (Rs.)
    20.00
  • Volume
    10266
  • MCap (Rs in Cr.)
    46.64
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-10.23
Operating Margin (%)
-8.94
Gross Profit Margin (%)
-15.43
Net Profit Margin (%)
-29.38
Total Debt/Equity
2.13
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

10 Nov 2017 - 18:32:00-The company reported standalone net loss during the quarter stood at Rs 2...
08 Aug 2017 - 19:55:00-The company reported standalone net loss during the quarter stood at Rs 7...
08 Aug 2017 - 19:55:00-The company reported standalone net loss during the quarter stood at Rs 7...
10 Jun 2015 - 11:12:00-Drug maker Bafna Pharmaceuticals Ltd on Wednesday said it has received the renewal certificate from ...

Announcements

18-Jan-2018
Bafna Pharmaceutical - Shareholding for the Period Ended December 31 2017
17-Jan-2018
Bafna Pharmaceutical - Statement Of Investor Complaints For The Quarter Dec 2017
05-Dec-2017
Bafna Pharmaceutical - Updates
05-Dec-2017
Bafna Pharmaceutical - Updates
07-Nov-2017
Bafna Pharmaceutical - Shareholders meeting

Religare Research

23 Jan 2018 | 09:55 AM
Highlights: • Agri markets kept trading with high volatility as no strong trend emerged with m...
23 Jan 2018 | 09:54 AM
The rupee ended at 63.86 to a dollar against 63.85 at close on Jan.19, steady against the dollar, as...
23 Jan 2018 | 09:35 AM
• Gold edged up on US government shutdown fears • Oil rebounded as dollar weakened • London copper c...
23 Jan 2018 | 07:00 AM
We’re in the F&O expiry week and the countdown for the Union Budget has also begun. We suggest keepi...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors33.42%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others15.83%

Peer Group

Company Intraday Graph
 DIL Ltd.
2,625.00(3.57)
3299
 Hester Biosciences Ltd.
1,686.95(3.96)
3572
 Merck Ltd.
1,441.70(-1.15)
3302
 Kovai Medical Center and Hospital Ltd.
1,300.05(0.55)
11816

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Bafna Pharmaceuticals Ltd.-0.150.30-4.90
NIFTY(S&P CNX)552.20898.851,119.15
BSE SENSEX2,129.373,633.263,894.11
BSE 500654.881,420.881,843.20

Corporate Details

Key Personal
B Kamlesh Kumar
Ind. Non-Executive Director
Bafna Mahaveer Chand
Chairman & Managing Director
K Sabitha
Non Ind.& Exe.Director
Key Address
Registered Office
Bafna Towers New?No.?68 ?Old?No. 299 ?? ? Thambu Chetty Street,Chennai (Madras),Tamil Nadu

Tel:044-25267517 42677555 25270992, Fax:044-25231264

info@bafnapharma.com
http://www.bafnapharma.com
Registrar Office
Cameo Corporate Services Ltd.
Add. :Subramanian Building No.1 Vth Floor Club House Road